EUVIMEDEUVIMED entdecken
Crossref

Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy

Arith Reyes, Roshni Rao, Lisa Wiechmann, Luona Sun, Stacy Ugras, Bret Taback

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.03.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Arith Reyes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Breast Surgery Division, Columbia University Medical Center, New York, NY. Electronic address: arr2242@cumc.columbia.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Sentinel Lymph Node Biopsy, Lymph Nodes, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSentinel Lymph Node BiopsyLymph NodesAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMiddle AgedRetrospective StudiesNeoadjuvant TherapyLymphatic MetastasisAdultIncidenceAgedAxillaChemotherapy, AdjuvantNeoplasm Recurrence, LocalLymph Node ExcisionNeoplasm StagingFollow-Up Studies

Stichwörter der Autor:innen

Axillary recurrenceClinical node negativeNeoadjuvant chemotherapyResidual occult nodal diseaseSentinel lymph node biopsy

Autor:innen und Institutionen

  • Department of Surgery, Breast Surgery Division, Columbia University Medical Center, New York, NY. Electronic address: arr2242@cumc.columbia.edu.
  • Department of Surgery, Breast Surgery Division, Columbia University Medical Center, New York, NY.

Zitieren

APA

Reyes, A., Rao, R., Wiechmann, L., Sun, L., Ugras, S., & Taback, B. (2025). Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.03.021

Vancouver

Reyes A, Rao R, Wiechmann L, Sun L, Ugras S, Taback B. Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.03.021

BibTeX
@article{Reyes2025,
  author = {Reyes, Arith and Rao, Roshni and Wiechmann, Lisa and Sun, Luona and Ugras, Stacy and Taback, Bret},
  title = {Incidence of Lymph Node Involvement in Clinically Node-Negative Breast Cancer Following Neoadjuvant Chemotherapy: Rationale for Selective Omission of Sentinel Lymph Node Biopsy},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.03.021}
}
Kostenlos starten →